Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that’s used to treat pain, inflammation, and fever. It’s one of the most popular drugs in its class, yet there are still many questions surrounding dosage, side effects, and more. In this blog post, we’ll be exploring Meloxicam and all you need to know as a medical professional. From proper dosage information to potential side effects and contraindications, this guide will help you provide the best care for your patients who are on the drug or considering it as an option. Read on to learn more!
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and swelling. It is also used to reduce fever. Meloxicam works by blocking the production of substances that cause inflammation.
The recommended dosage of meloxicam is 7.5 mg/day, taken as a single dose. For patients who require a higher dose, the maximum recommended dose is 15 mg/day. Meloxicam should be taken with food or milk to reduce stomach upset. The usual adult dosage of meloxicam for arthritis is 7.5 mg once daily. Some patients may require a higher dose of 15 mg once daily. The recommended starting dose for children is 0.125 mg/kg once daily, up to a maximum of 7.5 mg per day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
If you are considering starting a patient on meloxicam, there are some important things to keep in mind regarding safety and side effects. Here is a brief guide to help you get started: Important Safety Information: Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) and should be used with caution in patients with a history of NSAID-related gastric ulcers or gastrointestinal bleeding. Meloxicam may also increase the risk of serious cardiovascular events, such as heart attack or stroke. Therefore, it is important to weigh the potential risks and benefits of meloxicam therapy before starting a patient on this medication.
The most common side effects associated with meloxicam include headache, dizziness, abdominal pain, constipation, diarrhea, nausea, and vomiting. Less common side effects include rashes and allergic reactions. Common side effects of meloxicam include: nausea,vomiting upset stomach, diarrhea, constipation, dizziness. Less common side effects include: rashes, hives, itching, difficulty breathing or swallowing, wheezing swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs, hoarseness, joint pain, back pain, anxiety, blurred vision
There are a few things to keep in mind when monitoring patients taking meloxicam. First, it's important to monitor for signs of gastrointestinal bleeding. Meloxicam can increase the risk of GI bleeding, so it's important to watch for any signs of blood in the stool or vomit, or black, tarry stools. Second, it's important to monitor kidney function in patients taking meloxicam. This drug can cause fluid retention and worsen existing kidney problems. Therefore, it's important to check creatinine levels and urine output in patients taking this medication. Finally, it's important to monitor for signs of allergic reactions. Meloxicam can cause rashes, hives, itching, and difficulty breathing.
Meloxicam is a commonly prescribed nonsteroidal anti-inflammatory drug that has many uses and benefits. It can be an effective analgesic for moderate to severe pain relief and is also used to treat other medical conditions such as osteoarthritis, rheumatoid arthritis, and gout. As with any medication, it’s important to discuss the risks and benefits of using meloxicam with your patients before prescribing it. We hope that this guide has given you all the information you need to ensure that your patients are safe when taking this medication.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation